Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer. Stadler WM, Hayden A, von der Maase H, Roychowdhury D, Dogliotti L, Seymour L, Kaufmann D, Moore M, Department of Medicine, University of Chicago, Chicago, IL - Urol Oncol 2002;7:153-157

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 413-413

Elsevier

Access to resources Recommend Favorite

Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine

By        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 6, 2012-01 ,pp. : 1035-1038

Spandidos Publications

Access to resources Recommend Favorite

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Durk H.   Kneba M.   Dickgreber N.   Welte T.   Muller T.   Scholtze J.   Graeven U.   Jasiewicz Y.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 654-660

Elsevier

Access to resources Recommend Favorite

The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study

By Shen Hua   Li Xiao-Dong   Wu Chang-Ping   Yin Yong-Mei   Wang Rong-sheng   Shu Yong-Qian  

International Journal of Hyperthermia, Vol. 27, Iss. 1, 2011-02 ,pp. : 27-32

Informa Healthcare

Access to resources Recommend Favorite

Phase II Study of Pemetrexed Plus Gemcitabine in Advanced Pancreatic Cancer

By Kindler Hedy L.  

American Journal of Cancer, Vol. 4, Iss. 3, 2005-01 ,pp. : 185-191

Adis International

Access to resources Recommend Favorite